Videos
MaineHealth's Lizzy Mulcahy, DNP, and Dr. Tracy Jalbuena discuss the importance of sharing data with stakeholders and partners as well as how to get more patients involved and interested.
Challenges such as workforce shortages that are not getting any better and tight funding are driving the healthcare industry toward AI deployment, says Rob Havasy, HIMSS senior director of informatics strategy.
Data reveals that the people who are enrolling in Medicare Advantage have 50% more chronic conditions than people who are enrolling in Medicare fee-for-service, says Christie Teigland, Inovalon's VP of research science and advanced analytics.
Clinicians need to have integrity with how they present AI tools to their teams, focusing on how those tools can solve problems, says Josh Wymer, chief health information and data strategy officer at the Missouri Department of Health and Senior Services.
When implementing AI-powered assistants and ambient technologies, it is essential to know if what you are buying is an actual assistant and if it has features beyond just clinical documentation, says Punit Soni, founder and CEO of Suki.
The struggle is that "you can't just plop something in the middle of a system even though it has good effectiveness and expect people to change their behavior or trust it," says Dr. Cole Zanetti at Rocky Vista University College of Osteopathic Medicine.
Pro Rodeo Hall of Fame roping champion Stran Smith discusses how he discovered he had a hole in his heart and how his journey to finding treatment allowed him to return to roping and continue both his career and his lifestyle.
During an EHR transition, it is essential to keep the patient at the center of the transition, ensuring collaboration with clinicians and patients is done early, says Epic Emeritus CIO Kelli Garrison, founder and CEO of Verdant Consulting.
Jenn Wong, Abbott's divisional VP of global clinical and regulatory affairs, and Dr. Joshua Eloge, Rush associate director of the Woman's Board Depression Treatment Research Center, discuss their research on treatment-resistant depression.
If organizations are more transparent with clinicians and patients about AI adoption and deployment, stakeholders would feel more secure with it, says Nicole Ramage, senior market insights manager at HIMSS.